Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Adjuvant Chemotherapy in Stage III Colon Cancer
NCT00085163Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2004
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in colon cancer comparing Celecoxib + Chemotherapy with Placebo + Chemotherapy (2 arms). Primary endpoint: Disease-free survival. Started Mar 2004; status: completed.
02
Drugs
celecoxib
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00085163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085163.